CAJ | 학술논문

分析替米沙坦对高血压前期患者高敏C反应蛋白的影响。选取我院2011年1月~2013年1月期间收治的98例高血压前期患者，随机分为A、B两组，给予A组患者硝苯地平控释片治疗，给予B组患者替米沙坦治疗，对两组患者临床治疗效果进行对比。A、B两组患者组内对比，治疗后收缩压、舒张压均比之治疗前有明显改善，差异显著具有统计学意义（P＜0.05）；A、B两组组间对比，差异图统计学意义（P＞0.05）。替米沙坦可有效降低高血压前期患者高敏C反应蛋白，提高临床治疗效果，值得临床推广与应用。
분석체미사탄대고혈압전기환자고민C반응단백적영향。선취아원2011년1월~2013년1월기간수치적98례고혈압전기환자，수궤분위A、B량조，급여A조환자초분지평공석편치료，급여B조환자체미사탄치료，대량조환자림상치료효과진행대비。A、B량조환자조내대비，치료후수축압、서장압균비지치료전유명현개선，차이현저구유통계학의의（P＜0.05）；A、B량조조간대비，차이도통계학의의（P＞0.05）。체미사탄가유효강저고혈압전기환자고민C반응단백，제고림상치료효과，치득림상추엄여응용。
objective to analyze telmisartan high-sensitivity c-reactive protein in patients with prehypertension. Methods select our hospital from January 2011 to January 2011 admitted during the period of 98 patients with prehypertension, were randomly divided into A, B two groups, group A patients' nifedipine retard-20 tablet treatment, give telmisartan treatment group B patients, clinical therapeutic effect of two groups of patients were compared. Results within the group A, B two groups of patients, the systolic pressure, diastolic blood pressure after treatment were obviously improved than before treatment, significant difference statistically significant (P<0.05);Contrast, the difference between A and B two way figure statistical significance (P>0.05). Conclusion telmisartan can effectively reduce the early high-sensitivity c-reactive protein in patients with high blood pressure, improve the effect of clinical treatment, worthy of clinical popularization and application.